The immunogenic potential of generic version of low-molecular-weight heparins may not be the same as the branded products

Clin Appl Thromb Hemost. 2008 Jan;14(1):5-7. doi: 10.1177/1076029607312278.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Antibody Formation
  • Drugs, Generic / adverse effects
  • Drugs, Generic / standards*
  • Heparin, Low-Molecular-Weight / immunology*
  • Humans
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / immunology

Substances

  • Drugs, Generic
  • Heparin, Low-Molecular-Weight